Schedule 13G ownership disclosure
CYBIN INC
Common Stock, no par value · CUSIP: 23256X100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLC
Shares: 1,417,900.00 · Class: 2.8%
- ORBIMED CAPITAL LLC
Shares: 2,422,600.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-26-000189
- Form type
- SCHEDULE 13G
- Filer
- CYBIN INC.
- CIK
- CIK 1833141
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership